Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice

Therapeutic Potential of Cannabinoids in Psychosis

(2016) F. Markus Leweke et al.   BIOLOGICAL PSYCHIATRY

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia

(2016) Marc Fakhoury   MOLECULAR NEUROBIOLOGY

Impaired Reality Testing in Mice Lacking Phospholipase Cβ1: Observed by Persistent Representation-Mediated Taste Aversion

(2016) Hea-jin Kim et al.   PLoS One

Habenular CB1 Receptors Control the Expression of Aversive Memories

(2015) Edgar Soria-Gómez et al.   NEURON

Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications

(2015) Ashwini Rajasekaran et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

GABAergic mechanisms of hippocampal hyperactivity in schizophrenia

(2015) Stephan Heckers et al.   SCHIZOPHRENIA RESEARCH

Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease

(2014) Ryan Wyrofsky et al.   Expert Opinion on Drug Discovery

Mitochondrial dysfunction in schizophrenia: an evolutionary perspective

(2014) Vanessa F. Gonçalves et al.   HUMAN GENETICS

The endocannabinoid system controls food intake via olfactory processes

(2014) Edgar Soria-Gómez et al.   NATURE NEUROSCIENCE

Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia

(2014) Christine E. Marx et al.   PSYCHOPHARMACOLOGY

Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial

(2014) Claudine C. Hunault et al.   PSYCHOPHARMACOLOGY

Pregnenolone Can Protect the Brain from Cannabis Intoxication

(2014) Monique Vallée et al.   SCIENCE

Medial Temporal Lobe Structures and Hippocampal Subfields in Psychotic Disorders

(2014) Ian Mathew et al.   JAMA Psychiatry

Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence

(2013) T. Rubino et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Indications of a dose–response relationship between cannabis use and age at onset in bipolar disorder

(2013) Trine Vik Lagerberg et al.   PSYCHIATRY RESEARCH

Spicing things up: synthetic cannabinoids

(2013) Max Spaderna et al.   PSYCHOPHARMACOLOGY

Definition of psychotic disorders in the DSM-5 too radical, too conservative, or just right!

(2013) Rajiv Tandon   SCHIZOPHRENIA RESEARCH

Benzodiazepine harm: how can it be reduced?

(2012) Malcolm Lader   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD

(2012) Jing Han et al.   CELL

The Endocannabinoid System and Schizophrenia: Integration of Evidence

(2012) Erica Zamberletti et al.   CURRENT PHARMACEUTICAL DESIGN

Mitochondrial CB1 receptors regulate neuronal energy metabolism

(2012) Giovanni Bénard et al.   NATURE NEUROSCIENCE

Odor-mediated taste learning requires dorsal hippocampus, but not basolateral amygdala activity

(2012) Daniel S. Wheeler et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Glutamate Dysfunction in Hippocampus: Relevance of Dentate Gyrus and CA3 Signaling

(2012) C. A. Tamminga et al.   SCHIZOPHRENIA BULLETIN

Impaired Reality Testing in an Animal Model of Schizophrenia

(2011) Michael A. McDannald et al.   BIOLOGICAL PSYCHIATRY

Animal models of schizophrenia

(2011) CA Jones et al.   BRITISH JOURNAL OF PHARMACOLOGY

The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia

(2011) M.S. Ritsner   NEUROSCIENCE

The Hippocampal Formation in Schizophrenia

(2010) Carol A. Tamminga et al.   AMERICAN JOURNAL OF PSYCHIATRY

Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis

(2010) Nicolas A. Crossley et al.   BRITISH JOURNAL OF PSYCHIATRY

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia

(2010) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder

(2010) Michael S. Ritsner et al.   JOURNAL OF CLINICAL PSYCHIATRY

Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists

(2010) Patrik Roser et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Cannabis and psychosis/schizophrenia: human studies

(2009) Deepak Cyril D’Souza et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

(2009) Leonora E. Long et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antipsychotic drug actions on gene modulation and signaling mechanisms

(2009) Raffaella Molteni et al.   PHARMACOLOGY & THERAPEUTICS

The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

(2009) P. D. Morrison et al.   PSYCHOLOGICAL MEDICINE

Toward a Model of Impaired Reality Testing in Rats

(2009) M. McDannald et al.   SCHIZOPHRENIA BULLETIN

Cannabis and psychiatric disorders: it is not only addiction

(2008) F. Markus Leweke et al.   ADDICTION BIOLOGY

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia

(2008) Kuei Y. Tseng et al.   BEHAVIOURAL BRAIN RESEARCH

The Hope and Fear of Rimonabant

(2008) John S. Rumsfeld   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mitochondria in Neuroplasticity and Neurological Disorders

(2008) Mark P. Mattson et al.   NEURON